Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
11/24/2004 | CN1177048C Coding polynucleotide of human protein with function of suppressing cancer cell growth |
11/24/2004 | CN1177047C Coding polynucleotide of human protein with cancer suppressing function |
11/24/2004 | CN1176943C Novel recombinant human tissue factor pathway inhibitor active peptide and its preparation method |
11/23/2004 | US6822137 Nucleotide sequence encoding the enzyme I-SCEI and the uses thereof |
11/23/2004 | US6822075 Protein for use in the diagnosis and treatment of autoimmune, cancer and viral disorders |
11/23/2004 | US6822072 For diagnostics/forensics/gene therapy/chromosome mapping; expression vector design/secretion |
11/23/2004 | US6821767 Androgen receptor proteins, recombinant DNA molecules coding for such, and use of such compositions |
11/23/2004 | US6821755 Generating preferential protein in prokaryote; obtain cell, transform with expression vector containing preferential protein, express vector, recover proteins |
11/23/2004 | US6821754 Staphylococcus aureus genes and polypeptides |
11/23/2004 | US6821752 Methods and compositions for extracting proteins from cells |
11/23/2004 | US6821745 Regulation of human pyroglutamyl peptidase-like enzyme |
11/23/2004 | US6821743 Membrane protein for use in controlling vasodilation |
11/23/2004 | US6821519 Comprises polypeptide for detecting viral infection; immunoassays; immunostimulant |
11/23/2004 | CA2131709C Immune-enhancing agent for therapeutic use in immunocompromised hosts |
11/23/2004 | CA2116026C Hepatitis c assay utilizing recombinant antigens to c-100 region |
11/23/2004 | CA2084076C Family of map2 protein kinases |
11/23/2004 | CA2012482C Hepatitis c diagnostics and vaccines |
11/18/2004 | WO2004099424A2 Enrichment of enzymatic cleavage products |
11/18/2004 | WO2004099408A1 Novel protein and dna coding for the same |
11/18/2004 | WO2004099405A1 Human blood proteins expressed in monocot seeds |
11/18/2004 | WO2004099385A2 Telomere elongation |
11/18/2004 | WO2004099376A2 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity |
11/18/2004 | WO2004099332A2 Wood adhesives containing solid residues of biomass fermentations |
11/18/2004 | WO2004098490A2 Mesoderm and definitive endoderm cell populations |
11/18/2004 | WO2004019893A3 Modulators of angiogenesis |
11/18/2004 | WO2004011902A3 Improved systems and methods for analysis of protein post-translational modification |
11/18/2004 | WO2003093443A3 Alcam and alcam modulators |
11/18/2004 | WO2003037913A3 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
11/18/2004 | WO2002086087A3 Cytokine protein family |
11/18/2004 | US20040230043 Novel neurotrophic factors |
11/18/2004 | US20040230042 Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells |
11/18/2004 | US20040230038 Process for the stabilization of proteins in complex mixtures during their storage in aqueous solvents |
11/18/2004 | US20040230037 Chemokine receptor materials and methods |
11/18/2004 | US20040230034 Hybrid heterodimeric protein hormone and method of using same |
11/18/2004 | US20040230032 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
11/18/2004 | US20040229834 PREFERENTIAL CLASSIFICATON BETWEEN CANCER CELLS; OBTAIN SAMPLE, MONITOR SAMPLE FOR PREFERENTIAL ENZYMATIC ACTIVITY, EVALUATE DIFFERENTIATED CELLS; for of detecting presence or absence or level of a polynucleotide sequence encoding heparanase in a biological sample |
11/18/2004 | US20040229792 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
11/18/2004 | US20040229788 Cell surface molecule mediating cell adhesion and signal transmission |
11/18/2004 | US20040229783 Inhibiting an inflammatory response in a tissue comprising leptin receptor positive cells, by administering to the tissue an agent that inhibits the signaling activity of the leptin receptor that mediates intestinal inflammation, thereby inhibiting the inflammatory response in the tissue |
11/18/2004 | US20040229782 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
11/18/2004 | US20040229314 22438, 23553, 25278, and 26212 novel human sulfatases |
11/18/2004 | US20040229309 GANP protein |
11/18/2004 | US20040229305 Novel polynucleotides encoding useful polypeptides in corynebacterium glutamicum SSP. lactofermentum |
11/18/2004 | US20040229303 Novel thermostable proteolytic enzymes and uses thereof in peptide and protein synthesis |
11/18/2004 | US20040229284 Multiplex analysis of proteins |
11/18/2004 | US20040229278 Protein from plasma membrane of adipocytes; controlling glucose uptake |
11/18/2004 | US20040229277 Compositions and methods for the diagnosis and treatment of tumor |
11/18/2004 | US20040229274 Synaptic activation protein compositions and method |
11/18/2004 | US20040229266 RNA interference mediating small RNA molecules |
11/18/2004 | US20040229232 Compositions and methods for the diagnosis and treatment of tumor |
11/18/2004 | US20040229212 Recombinant human mannan-binding lectin |
11/18/2004 | US20040228857 administration of a human or humanized antibody expressed and glycosylated in a chinese hamster ovaries (CHO) cell expression system to treat T-cell mediated disorders, autoimmune disorders, cancer and infections; vasculitis, arthritis, lupus, psoriasis, multiple sclerosis, graft versus host disease |
11/18/2004 | US20040228798 A conjugated drug contains virus-like particle is joined to the antigen by a biotin molecule; bioassay; inhibiting HIV infection, viral infection |
11/18/2004 | DE19882755B4 Ein Fusionsprotein des hEGF und des humanen Angiogenins und ein Verfahren zu dessen Herstellung A fusion protein of hEGF and human angiogenin, and a process for its preparation |
11/18/2004 | DE10297331T5 Behandlung und Diagnose von Insulin-resistenten Zuständen Treatment and diagnosis of insulin-resistant conditions |
11/18/2004 | DE10047857B4 Verfahren zur selektiven biokatalytischen Modifizierung von Peptiden und Proteinen Biocatalytic process for the selective modification of peptides and proteins |
11/18/2004 | CA2684022A1 Mesoderm and definitive endoderm cell populations |
11/18/2004 | CA2525493A1 Human blood proteins expressed in monocot seeds |
11/18/2004 | CA2524799A1 Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production |
11/18/2004 | CA2524680A1 Enrichment of enzymatic cleavage products |
11/18/2004 | CA2524172A1 Cngh0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses |
11/18/2004 | CA2523765A1 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity |
11/18/2004 | CA2522345A1 Glycopegylation methods and proteins/peptides produced by the methods |
11/18/2004 | CA2487058A1 Mesoderm and definitive endoderm cell populations |
11/17/2004 | EP1477806A1 Method of determining ligand |
11/17/2004 | EP1477567A1 Method for recombinant production of mammalian proteins and proteins obtainable by such method |
11/17/2004 | EP1477566A1 Germ extract for cell-free protein synthesis and process for producing the same |
11/17/2004 | EP1477562A1 Transcriptional factor, transcriptional factor gene, recombinant vector containing transcriptional factor gene, koji-mold transformed by the vector and method of using koji-mold |
11/17/2004 | EP1477497A1 Humanized immunoglobulins and their production and use |
11/17/2004 | EP1476750A1 Method for producing a nucleosome preparation and use thereof in in vitro diagnosis of disseminated lupus erythematosus (dle) |
11/17/2004 | EP1476580A2 Multiple virus replicon culture systems |
11/17/2004 | EP1476563A2 Method for the recombination of genetic elements |
11/17/2004 | EP1476562A2 Over-expression of extremozyme genes in pseudomonads and closely related bacteria |
11/17/2004 | EP1476553A2 Gene for peripheral arterial occlusive disease |
11/17/2004 | EP1476545A2 Aggrecanase molecules |
11/17/2004 | EP1476541A2 Novel cytokine zcytor17 ligand |
11/17/2004 | EP1476469A1 MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR |
11/17/2004 | EP1476468A2 Human monoclonal antibody fab fragments directed against hcv e2 glycoprotein and endowed with in vitro neutralizing activity |
11/17/2004 | EP1476461A2 Immune-modulating peptide made of s. aureus enterotoxin b |
11/17/2004 | EP1476460A2 A nucleic acid encoding a g-protein-coupled receptor; and uses thereof |
11/17/2004 | EP1476456A2 Compositions and methods for surrogate antibody modulation of an immune response and transport |
11/17/2004 | EP1476185A2 Antibodies to cd40 |
11/17/2004 | EP1476180A2 Interleukin-2 mutants with reduced toxicity |
11/17/2004 | EP1476120A2 Treatment methods using anti-cd22 antibodies |
11/17/2004 | EP1337543A4 Streptavidin-binding peptides and uses thereof |
11/17/2004 | EP1105503B1 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE ALPHA1/BETA1 (hsGCALPHA1/BETA1) |
11/17/2004 | EP1086205A4 Methods of monitoring disease states and therapies using gene expression profiles |
11/17/2004 | EP1078266B1 HUMAN CHROMOGRANIN A (GgA) IMMUNOLOGIC ASSAY, ANTIBODIES, REAGENTS AND KITS FOR SAID ASSAY |
11/17/2004 | EP1073733B1 MUTATED PEPTIDE COMPOUNDS, DERIVED FROM hsp70, USEFUL IN CANCER IMMUNOTHERAPY |
11/17/2004 | EP0920501B8 Neuritin, a neurogene |
11/17/2004 | EP0868524B1 Improved barstar gene |
11/17/2004 | EP0852502B1 Lantibiotic mutants and chimeras of enhanced stability and activity |
11/17/2004 | EP0832185B1 Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods |
11/17/2004 | EP0801657B1 Retinoid x receptor-interacting polypeptides and related molecules and methods |
11/17/2004 | EP0731811B1 Chaperonin 10 |
11/17/2004 | EP0726957B1 RECOMBINANT DNase B DERIVED FROM STREPTOCOCCUS PYOGENES |
11/17/2004 | CN1547610A DNA for achieving high expression of growth hormone and use thereof |
11/17/2004 | CN1547608A Modified factor IX |
11/17/2004 | CN1547486A Antibodies to OPGL |
11/17/2004 | CN1547480A Methods of healing or preventing inflammation, damage and other changes that occur prior to, during or immediately after a myocardial event with thymosin beta 4, analogues, isoforms and other derivati |